Zhejiang Starry Pharmaceutical Co Ltd
603520
Company Profile
Business description
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Contact
No.1 Sitali Avenue
Modern Industrial Gathering District
Zhejiang Province, Xianju County
Taizhou City317306
CHNT: +86 57687718605
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,754
Stocks News & Analysis
stocks
Perplexing buyback from overvalued ASX share
Earnings continue to grow but investor expectations are too high.
stocks
Most popular shares in SMSFs
With data showing the continued rise of SMSFs, we explore the top stock picks of individual investors
stocks
Will China strong arm BHP into lower iron ore prices?
Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,199.80 | 17.70 | -0.19% |
| CAC 40 | 7,934.26 | 16.26 | 0.21% |
| DAX 40 | 24,387.93 | 146.47 | 0.60% |
| Dow JONES (US) | 46,067.58 | 587.98 | 1.29% |
| FTSE 100 | 9,442.87 | 66.53 | -0.70% |
| HKSE | 25,956.32 | 66.84 | 0.26% |
| NASDAQ | 22,694.61 | 490.18 | 2.21% |
| Nikkei 225 | 47,725.36 | 855.08 | -1.76% |
| NZX 50 Index | 13,259.98 | 91.94 | -0.69% |
| S&P 500 | 6,654.72 | 102.21 | 1.56% |
| S&P/ASX 200 | 8,891.10 | 18.60 | -0.21% |
| SSE Composite Index | 3,912.32 | 22.82 | 0.59% |